Activation of the CKI-CDK-Rb-E2F Pathway in Full Genome Hepatitis C Virus-expressing Cells*

Hepatitis C virus (HCV) causes persistent infection in hepatocytes, and this infection is, in turn, strongly associated with the development of hepatocellular carcinoma. To clarify the mechanisms underlying these effects, we established a Cre/loxP conditional expression system for the precisely self-trimmed HCV genome in human liver cells. Passage of hepatocytes expressing replicable full-length HCV (HCR6-Rz) RNA caused up-regulation of anchorage-independent growth after 44 days. In contrast, hepatocytes expressing HCV structural, nonstructural, or all viral proteins showed no significant changes after passage for 44 days. Only cells expressing HCR6-Rz passaged for 44 days displayed acceleration of CDK activity, hyperphosphorylation of Rb, and E2F activation. These results demonstrate that full genome HCV expression up-regulates the CDK-Rb-E2F pathway much more effectively than HCV proteins during passage.

[1]  C C Howe,et al.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.

[2]  S. Shurtleff,et al.  D-type cyclin-dependent kinase activity in mammalian cells , 1994, Molecular and cellular biology.

[3]  F. Shibasaki,et al.  Inhibition of Cytochrome c Release in Fas-mediated Signaling Pathway in Transgenic Mice Induced to Express Hepatitis C Viral Proteins* , 2001, The Journal of Biological Chemistry.

[4]  H. Esche,et al.  Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells. , 1997, European journal of biochemistry.

[5]  D. Grandér,et al.  Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines , 1997, Oncogene.

[6]  K. Shimotohno,et al.  Hepatitis C Virus Core Protein Inhibits Fas- and Tumor Necrosis Factor Alpha-Mediated Apoptosis via NF-κB Activation , 1999, Journal of Virology.

[7]  T. Morizane,et al.  Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection , 1998, The Lancet.

[8]  S. Sugano,et al.  Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. , 1995, Nucleic acids research.

[9]  Robert A. Weinberg,et al.  Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes , 1998, Molecular and Cellular Biology.

[10]  M. Campo,et al.  BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1 , 1998, Oncogene.

[11]  K. Meyer,et al.  Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype , 1996, Journal of virology.

[12]  K. Jeang,et al.  Hepatitis C virus core protein‐induced loss of LZIP function correlates with cellular transformation , 2000, The EMBO journal.

[13]  M. Kohara,et al.  Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. , 1995, Journal of hepatology.

[14]  M. Kohara,et al.  Hepatitis C virus structural proteins induce liver cell injury in transgenic mice , 1999, Journal of medical virology.

[15]  M. Honda,et al.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. , 2002, Gastroenterology.

[16]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[17]  R. Bartenschlager,et al.  Sequences in the 5′ Nontranslated Region of Hepatitis C Virus Required for RNA Replication , 2001, Journal of Virology.

[18]  L. Tsai,et al.  p35, the Neuronal-specific Activator of Cyclin-dependent Kinase 5 (Cdk5) Is Degraded by the Ubiquitin-Proteasome Pathway* , 1998, The Journal of Biological Chemistry.

[19]  C. Rice,et al.  Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture , 2003, Journal of Virology.

[20]  J. Feramisco,et al.  Microinjection of anti-p21 antibodies induces senescent Hs68 human fibroblasts to synthesize DNA but not to divide. , 1999, Cancer research.

[21]  R. Kawaguchi,et al.  Real-time detection system for quantification of hepatitis C virus genome. , 1999, Gastroenterology.

[22]  M. Lai,et al.  Hepatitis C Virus Core Protein Binds to the Cytoplasmic Domain of Tumor Necrosis Factor (TNF) Receptor 1 and Enhances TNF-Induced Apoptosis , 1998, Journal of Virology.

[23]  Yoshiharu Matsuura,et al.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.

[24]  R. Weinberg.  E2F and Cell Proliferation: A World Turned Upside Down , 1996, Cell.

[25]  H. Yonekawa,et al.  Efficient Conditional Transgene Expression in Hepatitis C Virus cDNA Transgenic Mice Mediated by the Cre/loxP System* , 1998, The Journal of Biological Chemistry.

[26]  L. Laimins,et al.  Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity , 1997, Journal of virology.

[27]  T. Takegami,et al.  Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells , 1995, Journal of virology.

[28]  J. Hiscott,et al.  Multiple signaling pathways leading to the activation of interferon regulatory factor 3. , 2002, Biochemical pharmacology.

[29]  W. Voigt,et al.  p53 and WAF1 are induced and Rb protein is hypophosphorylated during cell growth inhibition by the thymidylate synthase inhibitor ZD1694 (Tomudex). , 1997, Molecular pharmacology.

[30]  J. Nevins,et al.  A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Oren,et al.  Involvement of p21WAF1/Cip1, CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition , 1997, Oncogene.

[32]  J. Silver,et al.  Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line , 1999 .

[33]  F. Sablitzky,et al.  Inducible site-directed recombination in mouse embryonic stem cells. , 1996, Nucleic acids research.

[34]  X. Graña,et al.  Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). , 1995, Oncogene.

[35]  J. Nevins,et al.  Role of the Rb/E2F pathway in cell growth control , 1997, Journal of cellular physiology.

[36]  K. Taira,et al.  Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes. , 1995, Biochemistry.

[37]  R. Metcalf,et al.  p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. , 1993, Carcinogenesis.

[38]  D. Grandér,et al.  Molecular mechanisms underlying interferon-α-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins , 1999, Oncogene.

[39]  Katsuhiko Itoh,et al.  Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas , 2000, Nature Medicine.

[40]  Takeshi Tokuhisa,et al.  Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation , 2002, The Journal of experimental medicine.

[41]  M. Lai,et al.  Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor , 1997, Journal of virology.

[42]  M. Onji,et al.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Thorgeirsson,et al.  A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability , 1998, Nature Genetics.

[44]  B. Spiegelman,et al.  Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1 , 2001, Nature Medicine.

[45]  J. Park,et al.  Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. , 2000, Biochemical and biophysical research communications.

[46]  M. Ichikawa,et al.  The Native Form and Maturation Process of Hepatitis C Virus Core Protein , 1998, Journal of Virology.

[47]  T. Lee,et al.  Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines , 2001, Cancer Chemotherapy and Pharmacology.

[48]  Se-Hwan Yang,et al.  Hepatitis C Virus Core from Two Different Genotypes Has an Oncogenic Potential but Is Not Sufficient for Transforming Primary Rat Embryo Fibroblasts in Cooperation with the H-ras Oncogene , 1998, Journal of Virology.

[49]  J. Harbour,et al.  Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.